Clinical Trial: ONE-P TMS Military Veterans

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777380) titled 'ONE-P TMS Military Veterans' on Aug. 11.

Brief Summary: The aim of this study is to examine the feasibility and tolerability of a one-day protocol of repetitive transcranial magnetic stimulation with D-cycloserine (DCS) as an augmentation strategy in military personnel and veterans who have PTSD.

Study Start Date: Nov. 01, 2026

Study Type: INTERVENTIONAL

Condition: PTSD - Post Traumatic Stress Disorder

Intervention: DRUG: D-Cycloserine (DCS)

Participants randomized to the active treatment arm will receive DCS 125 mg orally, administered as one capsule around one hour before active aiTBS treatment.

DRUG: Placebo

Participants...